Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lechat

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Regulatory Toxicology and Pharmacology : RTP|December 20, 2011
Assessment of the health risks related to the presence of drug residues in water for human consumption: application to carbamazepinePaul Houeto, Aude Carton, Michel Guerbet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 6, 2007
Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis studyMichèle Kessler, Faiez Zannad, Philippe Lehert, et al.
Fundamental & Clinical Pharmacology|February 27, 2003
Relationships between the antihypertensive effects of bisoprolol and levels of plasma atrial natriuretic peptide in hypertensive patientsBeáta Baláti, Henry Phung, Françoise Pousset, et al.
Peptides|July 20, 2002
The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissueChristiane Barthelemy, Joelle Eurin, Philippe Lechat, et al.
Redox Report : Communications in Free Radical Research|August 22, 2002
Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failureDominique Bonnefont-Rousselot, Allal Mahmoudi, Nathalie Mougenot, et al.
European Heart Journal|February 10, 2007
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysisImad Abi Nasr, Anissa Bouzamondo, Jean-Sébastien Hulot, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 20, 2009
Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humansRenaud Respaud, Isabelle Benz-de Bretagne, Helene Blasco, et al.
European Journal of Pharmacology|November 27, 2002
Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulationFazia Brouri, Laurent Findji, Odile Mediani, et al.
Clinical Therapeutics|July 16, 2003
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteersErno A van Schaick, Philippe Lechat, Bart M M Remmerie, et al.
European Journal of Clinical Pharmacology|July 2, 2005
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearanceMarie Antignac, Jean Sebastien Hulot, Emmanuel Boleslawski, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Regulatory Toxicology and Pharmacology : RTP|December 20, 2011
Assessment of the health risks related to the presence of drug residues in water for human consumption: application to carbamazepinePaul Houeto, Aude Carton, Michel Guerbet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 6, 2007
Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis studyMichèle Kessler, Faiez Zannad, Philippe Lehert, et al.
Fundamental & Clinical Pharmacology|February 27, 2003
Relationships between the antihypertensive effects of bisoprolol and levels of plasma atrial natriuretic peptide in hypertensive patientsBeáta Baláti, Henry Phung, Françoise Pousset, et al.
Peptides|July 20, 2002
The mechanism of the angiotensin-converting enzyme inhibitor quinapril is not related to bradykinin level in heart tissueChristiane Barthelemy, Joelle Eurin, Philippe Lechat, et al.
Redox Report : Communications in Free Radical Research|August 22, 2002
Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failureDominique Bonnefont-Rousselot, Allal Mahmoudi, Nathalie Mougenot, et al.
European Heart Journal|February 10, 2007
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysisImad Abi Nasr, Anissa Bouzamondo, Jean-Sébastien Hulot, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 20, 2009
Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humansRenaud Respaud, Isabelle Benz-de Bretagne, Helene Blasco, et al.
European Journal of Pharmacology|November 27, 2002
Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulationFazia Brouri, Laurent Findji, Odile Mediani, et al.
Clinical Therapeutics|July 16, 2003
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteersErno A van Schaick, Philippe Lechat, Bart M M Remmerie, et al.
European Journal of Clinical Pharmacology|July 2, 2005
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearanceMarie Antignac, Jean Sebastien Hulot, Emmanuel Boleslawski, et al.
Pageof 11